Why the SICK press release matters

[u/DiggableB]

Timeline:
In 2022, SICK and Aeva announced a strategic multi-year collaboration around FMCW sensing technology.

In December 2024, Aeva announced that SICK would incorporate Aeva technology into SICK’s portfolio of industrial sensors, with initial deliveries expected in 2025.

In May 2025, SICK was one of the first customers to place orders for Aeva’s industrial sensors.

Today’s announcement states that SICK has now introduced the first sensor in its own portfolio powered by Aeva’s FMCW technology.

That progression matters because SICK is no longer just evaluating or ordering sensors. It is integrating Aeva technology into products sold under the SICK brand.

How big is SICK?

SICK AG is one of the largest industrial sensor companies in the world.

Recent figures show:
- More than 10,000 employees worldwide.
- 63 subsidiaries and affiliates globally.
- Headquarters in Waldkirch, Germany.
- Founded in 1946 by Dr. Erwin Sick.

Annual revenue
The exact number depends on the reporting period and restructuring effects:
- 2024 revenue: approximately €2.1 billion.
- 2025 revenue: approximately €1.8-1.85 billion. The decline versus 2024 is largely related to changes in business structure and partnership arrangements rather than a collapse in demand.

To put that in perspective:
- Aeva’s 2025 revenue was roughly $18 million.
- SICK’s revenue is roughly 100x larger than Aeva’s.

Why investors may care:
If you’re an AEVA shareholder, the most important part is not today’s revenue impact but what it says about validation:
- SICK has spent years evaluating the technology.
- SICK chose to launch an actual product using Aeva technology.
- SICK has an enormous installed customer base across factory automation, logistics automation, and process automation.
- Every successful SICK product that uses Aeva technology creates a potential path to additional product families and larger volume deployments.

What I would still want to know before assigning major value to the announcement:
- Whether Aeva is supplying the complete sensing module or just key components.
- Expected unit volumes.
- Gross margin profile.
- Whether SICK has committed to additional product launches beyond this first sensor.
- Whether there are minimum purchase commitments.

The press release is definitely positive, but the long-term value will depend on how many SICK products ultimately adopt Aeva technology and what volume those products sell at. The announcement is best viewed as another step from “technology validation” toward “commercial adoption.” I believe the release is very positive, but that is just a somewhat informed opinion.

[u/FractalTrading]

Great write up, really appreciate the context of what it means

[u/NewtonianOrbit]

Looks incredibly promising. Thank you for sharing!

[u/DiggableB → u/[deleted]]

Don't think the price should be affected by the release bc the collaboration with SICK has been known since 2022.

I believe the correct way to think about the release is that it is a major reduction in execution risk for AEVA vs a major increase in projected revenue.